This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Group Limited. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Rossella Guidetti: Innovator in HCV Inhibition
Introduction
Rossella Guidetti is a prominent inventor based in Stevenage, GB. She has made significant contributions to the field of antiviral research, particularly in the development of novel agents targeting Hepatitis C Virus (HCV). Her work has the potential to impact the treatment landscape for this viral infection.
Latest Patents
Rossella Guidetti holds a patent for her invention titled "4-(6-membered)-heteroaryl acyl pyrrolidine derivatives as HCV inhibitors." This patent represents a breakthrough in the search for effective antiviral agents, showcasing her innovative approach to combating HCV. She has 1 patent to her name, reflecting her dedication to advancing medical science.
Career Highlights
Guidetti is currently employed at Glaxo Group Limited, where she continues to push the boundaries of pharmaceutical research. Her role at this esteemed company allows her to collaborate with other talented scientists and contribute to the development of new therapeutic solutions.
Collaborations
Throughout her career, Rossella has worked alongside notable colleagues such as Gianpaolo Bravi and David Haigh. These collaborations have enriched her research and fostered an environment of innovation and creativity.
Conclusion
In summary, Rossella Guidetti is a trailblazer in the field of antiviral research, with a focus on HCV inhibitors. Her contributions through her patent and work at Glaxo Group Limited highlight her commitment to improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile